Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
出版年份 2021 全文链接
标题
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
作者
关键词
-
出版物
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 42, Issue 1, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-10-14
DOI
10.1161/atv.0000000000000147
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel method for quantification of lipoprotein(a)-cholesterol: Implications for improving accuracy of LDL-C measurements
- (2021) Calvin Yeang et al. JOURNAL OF LIPID RESEARCH
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
- (2021) Camilla Ditlev Lindhardt Johannesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
- (2021) Johanna F. Schachtl-Riess et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
- (2021) Gregory G. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly
- (2020) Mikaël Croyal et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
- (2020) Børge G. Nordestgaard et al. ATHEROSCLEROSIS
- ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis
- (2020) Romain Capoulade et al. HEART
- Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
- (2020) Vera A. Bittner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
- (2020) Johan G. Schnitzler et al. CIRCULATION RESEARCH
- Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
- (2020) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
- (2020) Anurag Mehta et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
- (2020) Byambaa Enkhmaa et al. Nutrients
- New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines
- (2020) Viraj Raygor et al. Current Cardiology Reports
- The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
- (2020) Devinder S. Dhindsa et al. Frontiers in Cardiovascular Medicine
- Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia
- (2020) Sergei N. Pokrovsky et al. Current Atherosclerosis Reports
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
- (2020) Michael Szarek et al. EUROPEAN HEART JOURNAL
- Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
- (2020) Ron C Hoogeveen et al. CLINICAL CHEMISTRY
- Lipoprotein(a) and Cardiovascular Disease
- (2020) Pia R Kamstrup CLINICAL CHEMISTRY
- Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)
- (2020) Santica M Marcovina et al. CLINICAL CHEMISTRY
- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease
- (2019) Donald M. Lloyd-Jones et al. CIRCULATION
- Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among Seven Ethnic Groups
- (2019) Guillaume Paré et al. CIRCULATION
- Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
- (2019) Michael B. Boffa et al. Nature Reviews Cardiology
- New Frontiers in Lp(a)-Targeted Therapies
- (2019) Matthew J. Borrelli et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. CIRCULATION
- Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis
- (2019) Brian T. Steffen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Use of lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Don P. Wilson, MD, on behalf of the Writing group
- (2019) Don P. Wilson et al. Journal of Clinical Lipidology
- Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
- (2019) Kang H. Zheng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines
- (2019) Scott M. Grundy et al. Journal of Clinical Lipidology
- Heritability of Apolipoprotein(a) Traits in Two-Generational African-American and Caucasian Families
- (2019) Byambaa Enkhmaa et al. JOURNAL OF LIPID RESEARCH
- Elevated Lipoprotein(a) and Risk of Ischemic Stroke
- (2019) Anne Langsted et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Potent reduction of plasma lipoprotein(a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis
- (2019) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein B Particles and Cardiovascular Disease
- (2019) Allan D. Sniderman et al. JAMA Cardiology
- HEART UK consensus statement on Lipoprotein(a): A call to action
- (2019) Jaimini Cegla et al. ATHEROSCLEROSIS
- Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
- (2019) A. Vuorio et al. JOURNAL OF INTERNAL MEDICINE
- Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a) Rx and IONIS-APO(a)-L Rx antisense oligonucleotide clinical trials
- (2018) Santica M. Marcovina et al. Journal of Clinical Lipidology
- Relationship of Lipoprotein(a) Molar Concentrations and Mass According to Lipoprotein(a) Thresholds and Apolipoprotein(a) Isoform Size
- (2018) Sotirios Tsimikas et al. Journal of Clinical Lipidology
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
- (2018) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High lipoprotein(a) and high risk of mortality
- (2018) Anne Langsted et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) catabolism: a case of multiple receptors
- (2018) Sally P.A. McCormick et al. PATHOLOGY
- The metabolism of lipoprotein (a): an ever-evolving story
- (2017) Gissette Reyes-Soffer et al. JOURNAL OF LIPID RESEARCH
- A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
- (2017) Salome Mack et al. JOURNAL OF LIPID RESEARCH
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
- (2017) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular DiseaseHighlights
- (2016) Eberhard Roeseler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis—Brief ReportHighlights: Table.
- (2016) Mehdi Afshar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- LPA Gene, Ethnicity, and Cardiovascular EventsClinical Perspective
- (2016) Sang-Rok Lee et al. CIRCULATION
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective
- (2016) Fleur M. van der Valk et al. CIRCULATION
- Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a)Novelty and Significance
- (2016) Monika Sharma et al. CIRCULATION RESEARCH
- Lipoprotein (a): a historical appraisal
- (2016) Karam M. Kostner et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein apheresis to treat elevated lipoprotein (a)
- (2016) Elisa Waldmann et al. JOURNAL OF LIPID RESEARCH
- Structure, function, and genetics of lipoprotein (a)
- (2016) Konrad Schmidt et al. JOURNAL OF LIPID RESEARCH
- Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
- (2016) Connor A. Emdin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein (a) measurements for clinical application
- (2015) Santica M. Marcovina et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
- (2015) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): impact by ethnicity and environmental and medical conditions
- (2015) Byambaa Enkhmaa et al. JOURNAL OF LIPID RESEARCH
- Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
- (2015) Romain Capoulade et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis: A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort
- (2014) B. J. Arsenault et al. Circulation-Cardiovascular Genetics
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes
- (2013) John J. Albers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
- (2012) Pia R. Kamstrup et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease
- (2012) Deepti Gurdasani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
- (2012) Anna Helgadottir et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) metabolism: Potential sites for therapeutic targets
- (2012) Jane Hoover-Plow et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects
- (2011) Salim S. Virani et al. CIRCULATION
- Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study)
- (2010) Stefano Volpato et al. AMERICAN JOURNAL OF CARDIOLOGY
- Review: Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease
- (2010) Srdjan Djurovic et al. CLINICAL GENETICS
- Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease
- (2010) Kåre Berg et al. CLINICAL GENETICS
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) Levels and Risk of Future Coronary Heart DiseaseLarge-Scale Prospective Data
- (2008) Anna Bennet ARCHIVES OF INTERNAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started